#Hangzhou #Cayman Islands #Ridgetech #RDGT

Ridgetech, Inc. Implements 1-for-150 Reverse Share Split

Ridgetech, Inc. (Nasdaq: RDGT), a wholesale distributor based in the Cayman Islands, has made an important announcement regarding its stock structure. On April 3, 2026, the company revealed its decision to execute a 1-for-150 reverse share split on its ordinary shares. This strategic move is set to take effect on April 7, 2026, at 5:00 PM Eastern Time.

The Mechanics of the Split

Under this reverse share split plan, for every 150 ordinary shares of Ridgetech held by investors, shareholders will receive one new ordinary share. This means that the total number of outstanding shares is expected to reduce significantly; from approximately 134,835,960 to about 898,906 post-split. It's important to note that this procedure will not result in the issuance of fractional shares. Instead, any fractions that may arise will be rounded up to the nearest whole share.

The new CUSIP number assigned to these shares following the split will be G2124G 203. Trading of the adjusted shares on the Nasdaq Capital Market will commence on the next trading day after the effective date, continuing under the ticker symbol RDGT.

Rationale Behind the Move

This reverse split has received unanimous approval from Ridgetech's board of directors and shareholders. The objective is to bolster the company’s market presence by increasing the per-share price, thus enhancing its attractiveness to current and potential investors. Typically, such corporate actions are taken to meet listing requirements or to manage share price perceptions, which can ultimately facilitate growth initiatives.

Company Overview

Ridgetech, Inc. is positioned as a leading distributor of pharmaceutical and healthcare products across China. With a robust infrastructure that includes both online and offline channels, Ridgetech leverages popular distribution platforms to reach a wide audience. The company believes that these distribution avenues provide significant opportunities to market its pharmaceutical products effectively.

As of the date of this announcement, the company is actively expanding its digital customer operations platform, aiming to streamline its distribution processes and improve overall efficiency. This focus underscores the firm’s commitment to adapting to the dynamic healthcare market while catering to evolving consumer demands.

Looking Ahead

Ridgetech remains optimistic about the future. The management points out that the company aims to foster valuable collaborations with key players in the pharmaceutical sector, which could yield beneficial outcomes for its business model. Furthermore, the reverse share split signifies an essential milestone for Ridgetech as it seeks to build a stronger financial foundation.

Investors and interested parties are encouraged to monitor Ridgetech’s progress through updates provided on the company’s website as well as in investor relations communications. The information shared will adhere to securities regulations, ensuring transparency as the company moves forward with its strategic goals.

For additional inquiries, or to view upcoming financial reports and corporate developments, stakeholders can reach out via the official contact channels.

In conclusion, while reverse share splits can be controversial in the investment community, they are utilized by companies like Ridgetech to correct market perceptions and focus on growth strategies. By adjusting the number of shares against its goal to innovate, Ridgetech positions itself for future success in the competitive pharmaceutical distribution landscape.